4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000007
10% owner bought 25,000 shares at an average $2.77 ($69,365)
From the SEC's structured data for this filing
Trades in this filing
Caissa Capital Management ltd. · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-04 | Purchase : show line 1 in the form | +15,000 | $2.79 | $41,882 | 1,332,700 | I |
| 2023-05-05 | Purchase : show line 2 in the form | +5,000 | $2.88 | $14,375 | 1,337,700 | I |
| 2023-05-08 | Purchase : show line 3 in the form | +5,000 | $2.62 | $13,108 | 1,342,700 | I |
| Open-market purchases · 25,000 sh · avg $2.77 · $69,365 | ||||||
Loading xslF345X04/primary_doc.xml…